LogicBio Therapeutics, Inc. (LOGC): Price and Financial Metrics
LogicBio Therapeutics, Inc. (LOGC)
Today's Latest Price: $8.01 USD
0.17 (2.17%)
Updated Feb 14 12:00am
Add LOGC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
LOGC Daily Price Range
LOGC 52-Week Price Range
LOGC Stock Price Chart More Charts
LOGC Price/Volume Stats
| Current price | $8.01 | 52-week high | $20.07 |
| Prev. close | $7.84 | 52-week low | $6.34 |
| Day low | $7.72 | Volume | 52,600 |
| Day high | $8.17 | Avg. volume | 104,345 |
| 50-day MA | $8.18 | Dividend yield | N/A |
| 200-day MA | $10.52 | Market Cap | 183.62M |
LogicBio Therapeutics, Inc. (LOGC) Company Bio
LogicBio Therapeutics, Inc. is a genome editing company, which engages in developing medicines to treat rare diseases in patients with significant unmet medical need. It focuses on the commercialization of specific genome editing and integration of the therapeutic transgene. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Cambridge, MA.
Loading social stream, please wait...